REG - Byotrol PLC - Senior Management Appointment

ByotrolAnnouncement

12/01/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220112:nRSL1208Ya&default-theme=true

RNS Number : 1208Y  Byotrol PLC  12 January 2022

Byotrol plc

("Byotrol" or the "Company")

Senior Management Appointment

Byotrol plc (AIM: BYOT), the infection prevention technology company, is
pleased to announce the appointment of Vivan Pinto as Chief Growth Officer
(CGO) of the Company.

Vivan is an experienced commercial leader with a blue-chip career spanning 20
years at Johnson and Johnson, Reckitt Benckiser and Pfizer, where he held
senior positions in General Management, Commercial and Marketing across the
globe. His most recent position was Area Managing Director for J&J
Consumer Health Africa.

At Byotrol, Vivan will be leading and growing our consumer business and will
also be central to developing group strategy.  His arrival completes a series
of recent investments in upgrading Byotrol's operational leadership team,
across the sales, marketing, business development, strategy, finance and
technology functions.

Vivan graduated from Duke University, North Carolina, with a BSc in Biology
before completing a MSc in IP Law from Queen Mary's College and an MBA from
Imperial College, both in London.  At the date of this announcement, he holds
200,000 ordinary shares of 0.25 pence each in the Company ("Ordinary Shares")
representing approximately 0.04 per cent. of the Company.

 

Commenting on the appointment, David Traynor, CEO of Byotrol plc, said:

"We are delighted to welcome Vivan Pinto into the team.  He has an excellent
track record in leading and growing very successful businesses across B2B and
B2C.  We are all looking forward to working with him."

 

Enquiries:

 

 Byotrol Plc
 John Langlands - Chairman                                       +44 (0)1925 742 000

 David Traynor - Chief Executive

 Chris Sedwell - Chief Finance Officer

 finnCap (Nominated Adviser and Broker)                          +44 (0)20 7220 0500
 Geoff Nash/Kate Bannatyne/George Dollemore - Corporate Finance
 Richard Chambers - ECM

 Flagstaff Strategic and Investor Communications                 +44 (0)20 7129 1474
 Tim Thompson/Andrea Seymour/Fergus Mellon                       byotrol@flagstaffcomms.com (mailto:byotrol@flagstaffcomms.com)

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and
control company, operating globally in the Healthcare, Industrial, Food and
Consumer sectors, providing low toxicity products with a broad-based and
targeted efficacy across all microbial classes; bacteria, viruses (including
coronavirus), fungi, moulds, mycobacteria and algae.

 

Byotrol's products can be used stand-alone or as ingredients within existing
products, where they can significantly improve their performance, especially
in personal hygiene, domestic and industrial disinfection, odour control, food
production and food management.

 

Byotrol develops and commercialises technologies that create easier, safer and
cleaner lives for everyone.

 

For more information, please go to byotrol.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBBMFTMTJBBRT